Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 10
  • Print publication year: 2010
  • Online publication date: February 2010

7. - Developmental exposures and implications for early and latent disease


1. SotoAM, MaffiniMV, SonnenscheinC.Neoplasia as development gone awry: the role of endocrine disruptors. Int J Androl 2008; 31(2): 288–93.
2. BernHA. The fragile fetus. In ColbornT, ClementC, ed. Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Science Publishing, 1992 9–15.
3. NewboldR.Lessons learned from perinatal exposure to diethylstilbestrol (DES). Toxicol Appl Pharmacol 2004; 199: 142–50.
4.National Institute of Health (NIH). DES Research Update, NIH Publication No. 00–4722. Bethesda, MD, 1999.
5. BarkerDJ, ErikssonJG, ForsenT, OsmondC.Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31(6): 1235–9.
6. KaufmanD, BanerjiMA, al. Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques. Diabetes 2007; 56(5): 1382–6.
7. LevinED. Fetal nicotinic overload, blunted sympathetic responsivity, and obesity. Birth Defects Res A Clin Mol Teratol 2005; 73(7): 481–4.
8. GluckmanPD, HansonMA, PinalC.The developmental origins of adult disease. Matern Child Nutr 2005; 1(3): 130–41.
9. HeindelJJ. Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction. Semin Reprod Med 2006; 24(3): 168–77.
10. HeindelJJ. Role of exposure to environmental chemicals in the developmental basis of disease and dysfunction. Reprod Toxicol 2007; 23(3): 257–9.
11. ColbornT, DumanoskiD, MyersJP. Our Stolen Future. Penguin Books USA, Inc., 1996.
12. CrainDA, JanssenSJ, EdwardsTM. et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril 2008; 90(4): 911–40.
13. HerbstAL, UlfelderH, PoskanzerDC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Eng J Med 1971; 284: 878–9.
14. HerbstAL, BernHA. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. New York: Hieme-Stratton, Inc., 1981.
15. GiustiRM, IwamotoK, HatchEE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995; 122(10): 778–88.
16. HatchEE, PalmerJR, al. Cancer risk in women exposed to diethylstilbestrol in utero. J Am Med Assoc. 1998; 280(7): 630–4.
17. NewboldRR, Padilla-BanksE, JeffersonWN. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 2006; 147 (Suppl 6): S11–17.
18. BlattJ, Van LeL, WeinerT, SailerS.Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol. J Pediatr Hematol Oncol 2003; 25(8): 635–6.
19. NewboldRR. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmnetal estrogens. Environ Health Perspect 1995; 103(7): 83–7.
20. HusebyRA. Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency. J Toxicol Environ Health Suppl 1976; 1: 177–92.
21. BernHA, MillsKT, OstranderPL. et al. Cervicovaginal abnormalities in BALB/c mice treated neonatally with sex hormones. Teratology 1984; 30(2): 267–74.
22. IguchiT, TakaseM, TakasugiN.Development of vaginal adenosis-like lesions and uterine epithelial stratification in mice exposed perinatally to diethylstilbestrol. Proc Soc Exp Biol Med 1986; 181(1): 59–65.
23. NewboldRR, BullockBC, McLachlanJA. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 1990; 50(23): 7677–81.
24. RothschildTC, CalhoonRE, BoylanES. Effects of diethylstilbestrol exposure in utero on the genital tracts of female ACI rats. Exp Mol Pathol 1988; 48(1): 59–76.
25. LeavittWW, EvansRW, HendryWJ 3rd. Etiology of DES-induced uterine tumors in the Syrian hamster. Adv Exp Med Biol 1981; 138: 63–86.
26. HoganMD, NewboldRR, McLachlanJA. Extrapolation of teratogenic responses observed in laboratory animals to humans. Branbury Report 26: Development Toxicology: Mechanisms and Risk. New York: Cold Spring Harbor Laboratory, 1987.
27. SwanSH, MainKM, al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005; 113(8): 1056–61.
28. Gray Jr LE, FosterPmd. Significance of experimental studies for assessing adverse effects of endocrine-disrupting chemicals. Pure Appl Chemistry 2003; 75: 2125–41.
29. Buck LouisGM, GrayLE, Jr, al. Environmental factors and puberty timing: expert panel research needs. Pediatrics 2008; 121 (Suppl. 3): S192–207.
30. GladenBC, RaganNB, RoganWJ. Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr 2000; 136(4): 490–6.
31. BlanckHM, MarcusM, TolbertPE. et al. Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology 2000; 11(6): 641–7.
32. RubinBS, MurrayMK, DamassaDA, KingJC, SotoAM. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001; 109(7): 675–80.
33. SelevanSG, RiceDC, HoganKA. et al. Blood lead concentration and delayed puberty in girls. N Engl J Med 2003; 348(16): 1527–36.
34. SaiyedH, DewanA, al. Effect of endosulfan on male reproductive development. Environ Health Perspect 2003; 111(16): 1958–62.
35. Baillie-HamiltonPF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002; 8(2): 185–92.
36. NewboldRR, Padilla-BanksE, JeffersonWN, HeindelJJ. Effects of endocrine disruptors on obesity. Int J Androl 2008; 31(2):201–8.
37. GrunF, WatanabeH, al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 2006; 20(9): 2141–55.
38. CollinsS.Overview of clinical perspectives and mechanisms of obesity. Birth Defects Res A Clin Mol Teratol 2005; 73(7): 470–1.
39. MokdadAH, FordES, BowmanBA. et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J Am Med Assoc 2003; 289(1): 76–9.
40. NayyarT, Bruner-TranKL, Piestrzeniewicz-UlanskaD, OsteenKG. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol 2007; 23(3): 326–36.
41. BairdDD, NewboldRR. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol 2005; 20(1): 81–4.
42. CookJD, DavisBJ, CaiSI. et al. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci USA 2005; 102: 8644–9.
43. ColbornT, vom SaalFS, SotoAM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993; 101(5): 378–84.
44. FentonSE, HammJT, BirnbaumLS, YoungbloodGL. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 2002; 67(1): 63–74.
45. BoylanES, CalhoonRE. Transplacental action of diethylstilbestrol on mammary carcinogenesis in female rats given one or two doses of 7,12-dimethylbenz(a)anthracene. Cancer Res 1983; 43(10): 4879–84.
46. NewboldRR, McLachlanJA. Neoplastic and non-neoplastic lesions in male reproductive organs following perinatal exposure to hormones and related substances. In MoriT, NagasawaH, eds. Toxicity of Hormones in Perinatal Life. Boca Raton, FL: CRC Press, Inc., 1988, 89–109.
47. vom SaalFS, TimmsBG, MontanoMM. et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997; 94: 2056–61.
48. PrinsGS, TangWY, BelmonteJ, HoSM. Developmental exposure to bisphenol A increases prostate cancer susceptibility in adult rats: epigenetic mode of action is implicated. Fertil Steril 2008; 89 (Suppl. 2): e41.
49. AnwayMD, CuppAS, UzumcuM, SkinnerMK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308(5727): 1466–9.
50. AnwayMD, RekowSS, SkinnerMK. Comparative anti-androgenic actions of vinclozolin and flutamide on transgenerational adult onset disease and spermatogenesis. Reprod Toxicol 2008; 26(2): 100–6.
51. KlipH, VerloopJ, van GoolJD. et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 2002; 359(9312): 1102–7.
52. BrouwersMM, FeitzWF, RoelofsLA. et al. Hypospadias: a transgenerational effect of diethylstilbestrol?Hum Reprod 2006; 21(3): 666–9.
53. Titus-ErnstoffL, TroisiR, HatchEE. et al. Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology 2008; 19(2): 251–7.
54. Gallou-KabaniC, VigeA, JunienC.Lifelong circadian and epigenetic drifts in metabolic syndrome. Epigenetics 2007; 2(3): 137–46.
55. HoSM, TangWY. Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases. Reprod Toxicol 2007; 23(3): 267–82.
56. JonesPA, BaylinSB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3(6): 415–28.
57. van DrielR, FranszPF, VerschurePJ. The eukaryotic genome: a system regulated at different hierarchical levels. J Cell Sci 2003; 116(20): 4067–75.
58. HoSM, TangWY, Belmonte deFrausto J, PrinsGS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006; 66(11): 5624–32.